Heart Rhythm Case Reports Publishes First Use of AI-Guided ECG Mapping for Left Bundle Branch Area Pacing

Heart Rhythm Case Reports Publishes First Use of AI-Guided ECG Mapping for Left Bundle Branch Area Pacing Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, has announced the publication of a groundbreaking case report in Heart Rhythm Case…

Read MoreHeart Rhythm Case Reports Publishes First Use of AI-Guided ECG Mapping for Left Bundle Branch Area Pacing

AGC Biologics Launches Cellular and Genetic Technologies Division to Boost Nine Market-Approved Products

AGC Biologics Launches Cellular and Genetic Technologies Division to Boost Nine Market-Approved Products AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the creation of its new Cell and Gene Technologies division. This strategic move is designed…

Read MoreAGC Biologics Launches Cellular and Genetic Technologies Division to Boost Nine Market-Approved Products

Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints

Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints Sinaptica Therapeutics, Inc., a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced the publication of positive results from its 52-week Phase 2…

Read MorePositive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints

ELIQUENT Life Sciences Acquires Truliant Consulting to Expand Pharmacovigilance Platform

ELIQUENT Life Sciences Acquires Truliant Consulting to Expand Pharmacovigilance Platform ELIQUENT Life Sciences, a global leader in regulatory, quality, and safety consulting, has announced the strategic acquisition of Truliant Consulting, a highly regarded pharmacovigilance, risk management, and regulatory compliance advisory…

Read MoreELIQUENT Life Sciences Acquires Truliant Consulting to Expand Pharmacovigilance Platform

Johnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership

Johnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., further strengthening its position in the neuroscience sector. Intra-Cellular Therapies will now function as a…

Read MoreJohnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership

Click Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments

Click Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments Click Therapeutics, Inc. (“Click”), a pioneer in the development of prescription medical treatments, has unveiled a new brand identity and website to reflect its evolution and…

Read MoreClick Therapeutics Unveils New Brand Identity to Strengthen Leadership in Software as Prescription Treatments

Geneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization

Geneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization Geneoscopy, Inc., a life sciences company focused on advancing gastrointestinal health through innovative diagnostic tests, has announced the appointment of Amit Bhalla as its Chief Financial Officer (CFO). With…

Read MoreGeneoscopy Appoints Amit Bhalla as CFO to Drive Growth and Commercialization

NanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia

NanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia NanoVibronix, Inc. (NASDAQ: NAOV), a leading medical technology company specializing in non-invasive therapeutic devices, has announced the renewal and expansion of its exclusive three-year distribution agreement with Dukehill Healthcare Pty Ltd.…

Read MoreNanoVibronix Announces Distribution Agreement with Dukehill Healthcare in Australia